Subscribe to RSS

DOI: 10.1055/s-0045-1812872
The Impact of Macrovascular Disease in People with Type 2 Diabetes on Ramadan Fasting Practices and Glycemic Outcomes: Insights from a Multinational Real-World Study
Authors
Funding and Sponsorship This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Abstract
Background
The International Diabetes Federation–Diabetes and Ramadan (IDF-DAR) Risk Score is widely used to guide fasting recommendations for individuals with type 2 diabetes mellitus (T2D) during the month of Ramadan. Many patients with macrovascular disease (MVD) are typically classified as high-risk and advised not to fast. However, real-world practices may differ from guideline recommendations.
Objectives
This article evaluates fasting behaviors and glycemic outcomes during Ramadan among individuals with and without MVD using multinational, real-world data.
Patients and Methods
This retrospective, observational cohort study analyzed data from the 2020–2022 DAR Global Survey. The survey included 12,529 Muslim adults with T2D from seven global regions. Participants with documented MVD (n = 1,520) were compared to those without MVD as a control (n = 11,010). Key outcomes included the number of fasting days, the incidence of hypoglycemia and hyperglycemia, and the frequency of breaking fast due to glycemic events. Multivariable logistic regression adjusted for clinical and demographic covariates.
Results
Fewer individuals with MVD intended to fast (68.5% vs. 87.6%, p = 0.04), however, among those who fasted, the average number of fasting days was similar (26.9 vs. 27.7). After adjustment of all covariates such diabetes duration, age, use of insulin, level of glycosylated hemoglobin, as well as presence of other diabetes-related complication, MVD was associated with higher odds of breaking fast due to hypoglycemia (adjusted odds ratio 1.25, 95% confidence interval 1.02–1.54, p ≤ 0.05), but not with higher incidence of hypoglycemia (p = 0.51), hyperglycemia (p = 0.71), or severe events.
Conclusion
Many individuals with T2D and MVD opted not to fast. However, the majority fasted during Ramadan without increased adverse outcomes apart from increased rates of breaking fast due to hypoglycemia. This data offers insights into real-world fasting behaviors and outcomes. Further studies are needed to investigate the impact of various MVD subtypes and severities.
Keywords
type 2 diabetes mellitus - macrovascular disease - Ramadan - hypoglycemia - IDF-DAR - fasting - risk stratificationAuthors' Contributions
All authors contributed toward conception, data collection, writing, and final approval of the manuscript.
Compliance with Ethical Principles
Ethical approval was granted for the initial DAR Global Survey from Dubai Health Authority.
Data Availability Statement
The data supporting this article can be made available by a reasonable request to the corresponding author.
Publication History
Article published online:
31 October 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Hassanein M, Al-Arouj M, Hamdy O. et al; International Diabetes Federation (IDF), in collaboration with the Diabetes and Ramadan (DAR) International Alliance. Diabetes and Ramadan: practical guidelines. Diabetes Res Clin Pract 2017; 126: 303-316
- 2 Al-Arouj M, Assaad-Khalil S, Buse J. et al. Recommendations for management of diabetes during Ramadan: update 2010. Diabetes Care 2010; 33 (08) 1895-1902
- 3 Salti I, Bénard E, Detournay B. et al; EPIDIAR study group. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 2004; 27 (10) 2306-2311
- 4 Hassanein M, Rashid F, Elsayed M. et al. Assessment of risk of fasting during Ramadan under optimal diabetes care, in high-risk patients with diabetes and coronary heart disease through the use of FreeStyle Libre flash continuous glucose monitor (FSL-CGMS). Diabetes Res Clin Pract 2019; 150: 308-314
- 5 Babineaux SM, Toaima D, Boye KS. et al. Multi-country retrospective observational study of the management and outcomes of patients with type 2 diabetes during Ramadan in 2010 (CREED). Diabet Med 2015; 32 (06) 819-828
- 6 Hassanein M, Afandi B, Yakoob Ahmedani M. et al. Diabetes and Ramadan: practical guidelines 2021. Diabetes Res Clin Pract 2022; 185: 109185
- 7 Afandi B, Hassanein M, Suliman M, Hafidh K. Personalized risk reduction strategies utilizing the diabetes and Ramadan risk calculator: a narrative review. J Diabetes Metab Disord 2024; 24 (01) 30
- 8 Afandi B, Beshyah S, Hassanein M, Jabbar A, Khalil A. The individualization of care for people with diabetes during Ramadan fasting: a narrative review. Ibnosina J Med Biomed Sci 2020; 12 (02) 98-107
- 9 Afandi B, Kaplan W, Al Kuwaiti F, Dahmani KA, Nagelkerke N. Ramadan challenges: fasting against medical advice. J Nutr Fast Health 2017; 5 (03) 133-137
- 10 Alfadhli EM, Alharbi TS, Alrotoie AM. et al. Validity of the International Diabetes Federation risk stratification score of Ramadan fasting in individuals with diabetes mellitus. Saudi Med J 2024; 45 (01) 86-92
- 11 Aziz KM. Effect of fasting Ramadan in diabetes control status - application of extensive diabetes education, serum creatinine with HbA1c statistical ANOVA and regression models to prevent hypoglycemia. Recent Pat Endocr Metab Immune Drug Discov 2013; 7 (03) 233-251
- 12 Trepanowski JF, Bloomer RJ. The impact of religious fasting on human health. Nutr J 2010; 9: 57
- 13 Gnanou JV, Caszo BA, Khalil KM, Abdullah SL, Knight VF, Bidin MZ. Effects of Ramadan fasting on glucose homeostasis and adiponectin levels in healthy adult males. J Diabetes Metab Disord 2015; 14: 55
- 14 Kul S, Savaş E, Öztürk ZA, Karadağ G. Does Ramadan fasting alter body weight and blood lipids and fasting blood glucose in a healthy population? A meta-analysis. J Relig Health 2014; 53 (03) 929-942
- 15 Hassanein M, Abdelgadir E, Bashier A. et al. The role of optimum diabetes care in form of Ramadan focused diabetes education, flash glucose monitoring system and pre-Ramadan dose adjustments in the safety of Ramadan fasting in high risk patients with diabetes. Diabetes Res Clin Pract 2019; 150: 288-295
- 16 Gholampoor N, Sharif AH, Mellor D. The effect of observing religious or faith-based fasting on cardiovascular disease risk factors: a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis 2024; 34 (05) 1097-1109
- 17 Yousefi B, Faghfoori Z, Samadi N. et al. The effects of Ramadan fasting on endothelial function in patients with cardiovascular diseases. Eur J Clin Nutr 2014; 68 (07) 835-839
- 18 Desouza C, Salazar H, Cheong B, Murgo J, Fonseca V. Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring. Diabetes Care 2003; 26 (05) 1485-1489
- 19 Farooq Q, Ghaffar T, Malik SE, Aamir AUH. Safety of high-risk diabetic patients during Ramadan at a tertiary care hospital in Pakistan, practicing updated IDF DAR guidelines. Pak J Med Sci 2024; 40 (05) 829-834
- 20 Rashid F, Yaseen N, Mahmud MS. et al. Frequency of cardiac events in patients with or without diabetes admitted to a cardiac unit of Dubai Hospital before, during, and after Ramadan. J Diabetes Endocr Pract 2025; 8: 32-38
